showed a trendP = 0.13
In our model, TGFβ inhibition reduced early intracranial tumor burden, and survival showed a trend toward prolongation (MST 15 vs. 14 days; P = 0.13, log-rank).
In our model, TGFβ inhibition reduced early intracranial tumor burden, and survival showed a trend toward prolongation (MST 15 vs. 14 days; P = 0.13, log-rank).